Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
post your news I subscribe newsletter I contact us
29.08.2008 Oxford Biomedica plc Unaudited Interim Results for the Six Months Ended 30 June 2008
26.08.2008 ADAGIO trial results show Azilect® slows progression of Parkinson's disease
25.08.2008 Cell Therapeutics, Inc. Announces Reverse Stock Split
22.08.2008 FDA Approves NplateTM for Long-Term Treatment of Adult Chronic ITP
20.08.2008 JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia
20.08.2008 Avantogen Ltd Receives Commitment of $1M in a Private Placement
19.08.2008 BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
19.08.2008 European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
19.08.2008 Evolution in the ribosome
15.08.2008 Evidence of activity seen in new data from ASA404 prostate cancer trial
13.08.2008 MOLOGEN AG publishes results for the first half-year of 2008
13.08.2008 Genentech Special Committee of Independent Directors Responds to Roche Proposal
13.08.2008 Chronic pain among women may be down to low levels of vitamin D
13.08.2008 Depression prompts thoughts of death in cancer patients
12.08.2008 Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
11.08.2008 Tripep carries out a Rights Issue
11.08.2008 Cambridge Consultants brings its Vena platform to the Continua Health Alliance
08.08.2008 New therapeutic platform technology tackles major diseases
08.08.2008 First step towards switching off breast cancer and leukaemia
06.08.2008 Active Biotech AB Interim Report January-June 2008